Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01889 (
ankylosing spondylitis
)
5,717
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The integrin
LFA-1
(CD11a/CD18) is a cell surface adhesion molecule required for leukocyte extravasation and subsequent immune and inflammatory responses. Rapid transition between nonadherent and adherent states of
LFA-1
is of key importance to Ag-specific recognition of T lymphocytes. In this paper,
LFA-1
-mediated adhesiveness of peripheral blood (PB) and synovial fluid (SF) T lymphocytes to affinity-purified ICAM-1-coated plates was studied in patients with rheumatoid arthritis (RA) and in patients with non-RA panels, including osteoarthritis,
ankylosing spondylitis
, erythema nodosum, pseudogout, and pustulosis.
LFA-1
-mediated adhesiveness of SF T lymphocytes was not observed in any of the 10 non-RA patients studied, although cross-linking of the TCR on lymphocytes from these patients rapidly converted
LFA-1
to an adhesive state. In contrast, SF T lymphocytes from 10 of 12 RA patients exhibited
LFA-1
-mediated adhesiveness without a requirement for cross-linking of the TCR. No difference was seen in the cell surface density of
LFA-1
between non-RA and RA T lymphocytes, suggesting that the difference in adhesiveness was due to a high avidity state of
LFA-1
on SF T lymphocytes in RA. Furthermore, exposure of PB T lymphocytes, which showed a low avidity state of
LFA-1
, to whole SF from RA patients that was depleted of T lymphocytes could induce a high avidity state of
LFA-1
in vitro. Cellfree SF from RA patients also could stimulate adhesiveness, although to a lesser extent. These data suggest the existence of a
LFA-1
-activating environment that is selectively found in SF from RA patients.
...
PMID:High avidity state of leukocyte function-associated antigen-1 on rheumatoid synovial fluid T lymphocytes. 756 Nov 25